{
  "ticker": "PFE",
  "company_name": "Pfizer Inc.",
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - General",
  "analysis_date": "2025-12-18",
  "business_quality_score": 9.2,
  "financial_health_score": 7.5,
  "valuation_score": 9,
  "growth_score": 1.7,
  "sentiment_score": 7,
  "institutional_score": 8.1,
  "risk_score": 8.5,
  "conviction_score": 73.0,
  "conviction_tier": "MEDIUM",
  "bull_case": "Quality healthcare company with high quality business, strong balance sheet",
  "bear_case": "Sector rotation risk",
  "market_cap": 142370127872,
  "pe_ratio": 14.55814,
  "debt_to_equity": 66.531,
  "profit_margin": 0.15654999,
  "revenue_growth": -0.059,
  "current_price": 25.04,
  "analyst_target": 28.62292,
  "recommendation": "buy",
  "position_size_modifier": 1.23
}